 | • レポートコード：MRC2-11QY02522 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗体のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体）市場規模、用途別（病院、介護施設、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗体の競争状況、市場シェア ・世界の抗体市場：種類別市場規模 2015年-2020年（モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体） ・世界の抗体市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体） ・世界の抗体市場：用途別市場規模 2015年-2020年（病院、介護施設、研究機関） ・世界の抗体市場：用途別市場規模予測 2021年-2026年（病院、介護施設、研究機関） ・北米の抗体市場分析：米国、カナダ ・ヨーロッパの抗体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、F. Hoffmann-La Roche、Johnson & Johnson Services、Amgen、Bristol-Myers Squibb、AbbVie、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Antibodies Market
The global Antibodies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antibodies Scope and Market Size
Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibodies market is segmented into
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates
Segment by Application, the Antibodies market is segmented into
Hospitals
Long-term care facilities
Research institutes
Regional and Country-level Analysis
The Antibodies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibodies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibodies Market Share Analysis
Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibodies business, the date to enter into the Antibodies market, Antibodies product introduction, recent developments, etc.
The major vendors covered:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson Services
Amgen
Bristol-Myers Squibb
AbbVie
Eli Lilly
…
1 Study Coverage
1.1 Antibodies Product Introduction
1.2 Market Segments
1.3 Key Antibodies Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibodies Market Size Growth Rate by Type
1.4.2 Monoclonal antibodies
1.4.3 Polyclonal antibodies
1.4.4 Antibody drug conjugates
1.5 Market by Application
1.5.1 Global Antibodies Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Long-term care facilities
1.5.4 Research institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibodies Market Size, Estimates and Forecasts
2.1.1 Global Antibodies Revenue 2015-2026
2.1.2 Global Antibodies Sales 2015-2026
2.2 Global Antibodies, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibodies Competitor Landscape by Players
3.1 Antibodies Sales by Manufacturers
3.1.1 Antibodies Sales by Manufacturers (2015-2020)
3.1.2 Antibodies Sales Market Share by Manufacturers (2015-2020)
3.2 Antibodies Revenue by Manufacturers
3.2.1 Antibodies Revenue by Manufacturers (2015-2020)
3.2.2 Antibodies Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibodies Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibodies Revenue in 2019
3.2.5 Global Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibodies Price by Manufacturers
3.4 Antibodies Manufacturing Base Distribution, Product Types
3.4.1 Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibodies Product Type
3.4.3 Date of International Manufacturers Enter into Antibodies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antibodies Market Size by Type (2015-2020)
4.1.1 Global Antibodies Sales by Type (2015-2020)
4.1.2 Global Antibodies Revenue by Type (2015-2020)
4.1.3 Antibodies Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibodies Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibodies Sales Forecast by Type (2021-2026)
4.2.2 Global Antibodies Revenue Forecast by Type (2021-2026)
4.2.3 Antibodies Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antibodies Market Size by Application (2015-2020)
5.1.1 Global Antibodies Sales by Application (2015-2020)
5.1.2 Global Antibodies Revenue by Application (2015-2020)
5.1.3 Antibodies Price by Application (2015-2020)
5.2 Antibodies Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibodies Sales Forecast by Application (2021-2026)
5.2.2 Global Antibodies Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibodies Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antibodies by Country
6.1.1 North America Antibodies Sales by Country
6.1.2 North America Antibodies Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibodies Market Facts & Figures by Type
6.3 North America Antibodies Market Facts & Figures by Application
7 Europe
7.1 Europe Antibodies by Country
7.1.1 Europe Antibodies Sales by Country
7.1.2 Europe Antibodies Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibodies Market Facts & Figures by Type
7.3 Europe Antibodies Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antibodies by Region
8.1.1 Asia Pacific Antibodies Sales by Region
8.1.2 Asia Pacific Antibodies Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibodies Market Facts & Figures by Type
8.3 Asia Pacific Antibodies Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antibodies by Country
9.1.1 Latin America Antibodies Sales by Country
9.1.2 Latin America Antibodies Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibodies Market Facts & Figures by Type
9.3 Central & South America Antibodies Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibodies by Country
10.1.1 Middle East and Africa Antibodies Sales by Country
10.1.2 Middle East and Africa Antibodies Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibodies Market Facts & Figures by Type
10.3 Middle East and Africa Antibodies Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibodies Products Offered
11.1.5 Novartis Related Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Description and Business Overview
11.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche Antibodies Products Offered
11.2.5 F. Hoffmann-La Roche Related Developments
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Corporation Information
11.3.2 Johnson & Johnson Services Description and Business Overview
11.3.3 Johnson & Johnson Services Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Services Antibodies Products Offered
11.3.5 Johnson & Johnson Services Related Developments
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description and Business Overview
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Antibodies Products Offered
11.4.5 Amgen Related Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Description and Business Overview
11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb Antibodies Products Offered
11.5.5 Bristol-Myers Squibb Related Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Description and Business Overview
11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Antibodies Products Offered
11.6.5 AbbVie Related Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description and Business Overview
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Antibodies Products Offered
11.7.5 Eli Lilly Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibodies Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antibodies Market Estimates and Projections by Region
12.1.1 Global Antibodies Sales Forecast by Regions 2021-2026
12.1.2 Global Antibodies Revenue Forecast by Regions 2021-2026
12.2 North America Antibodies Market Size Forecast (2021-2026)
12.2.1 North America: Antibodies Sales Forecast (2021-2026)
12.2.2 North America: Antibodies Revenue Forecast (2021-2026)
12.2.3 North America: Antibodies Market Size Forecast by Country (2021-2026)
12.3 Europe Antibodies Market Size Forecast (2021-2026)
12.3.1 Europe: Antibodies Sales Forecast (2021-2026)
12.3.2 Europe: Antibodies Revenue Forecast (2021-2026)
12.3.3 Europe: Antibodies Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibodies Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibodies Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibodies Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibodies Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibodies Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibodies Sales Forecast (2021-2026)
12.5.2 Latin America: Antibodies Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibodies Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibodies Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibodies Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibodies Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibodies Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antibodies Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibodies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antibodies Market Segments
Table 2. Ranking of Global Top Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibodies Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal antibodies
Table 5. Major Manufacturers of Polyclonal antibodies
Table 6. Major Manufacturers of Antibody drug conjugates
Table 7. Global Antibodies Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Antibodies Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Antibodies Sales by Regions 2015-2020 (K Units)
Table 10. Global Antibodies Sales Market Share by Regions (2015-2020)
Table 11. Global Antibodies Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Antibodies Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Antibodies Sales Share by Manufacturers (2015-2020)
Table 14. Global Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibodies as of 2019)
Table 16. Antibodies Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Antibodies Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Antibodies Price (2015-2020) (USD/Unit)
Table 19. Antibodies Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Antibodies Product Type
Table 21. Date of International Manufacturers Enter into Antibodies Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibodies Sales by Type (2015-2020) (K Units)
Table 24. Global Antibodies Sales Share by Type (2015-2020)
Table 25. Global Antibodies Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Antibodies Revenue Share by Type (2015-2020)
Table 27. Antibodies Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Antibodies Sales by Application (2015-2020) (K Units)
Table 29. Global Antibodies Sales Share by Application (2015-2020)
Table 30. North America Antibodies Sales by Country (2015-2020) (K Units)
Table 31. North America Antibodies Sales Market Share by Country (2015-2020)
Table 32. North America Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Antibodies Revenue Market Share by Country (2015-2020)
Table 34. North America Antibodies Sales by Type (2015-2020) (K Units)
Table 35. North America Antibodies Sales Market Share by Type (2015-2020)
Table 36. North America Antibodies Sales by Application (2015-2020) (K Units)
Table 37. North America Antibodies Sales Market Share by Application (2015-2020)
Table 38. Europe Antibodies Sales by Country (2015-2020) (K Units)
Table 39. Europe Antibodies Sales Market Share by Country (2015-2020)
Table 40. Europe Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Antibodies Revenue Market Share by Country (2015-2020)
Table 42. Europe Antibodies Sales by Type (2015-2020) (K Units)
Table 43. Europe Antibodies Sales Market Share by Type (2015-2020)
Table 44. Europe Antibodies Sales by Application (2015-2020) (K Units)
Table 45. Europe Antibodies Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Antibodies Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Antibodies Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Antibodies Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Antibodies Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Antibodies Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Antibodies Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Antibodies Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Antibodies Sales Market Share by Application (2015-2020)
Table 54. Latin America Antibodies Sales by Country (2015-2020) (K Units)
Table 55. Latin America Antibodies Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Antibodies Revenue Market Share by Country (2015-2020)
Table 58. Latin America Antibodies Sales by Type (2015-2020) (K Units)
Table 59. Latin America Antibodies Sales Market Share by Type (2015-2020)
Table 60. Latin America Antibodies Sales by Application (2015-2020) (K Units)
Table 61. Latin America Antibodies Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Antibodies Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Antibodies Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Antibodies Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Antibodies Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Antibodies Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Antibodies Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Antibodies Sales Market Share by Application (2015-2020)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Major Businesses
Table 72. Novartis Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Novartis Product
Table 74. Novartis Recent Development
Table 75. F. Hoffmann-La Roche Corporation Information
Table 76. F. Hoffmann-La Roche Description and Major Businesses
Table 77. F. Hoffmann-La Roche Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. F. Hoffmann-La Roche Product
Table 79. F. Hoffmann-La Roche Recent Development
Table 80. Johnson & Johnson Services Corporation Information
Table 81. Johnson & Johnson Services Description and Major Businesses
Table 82. Johnson & Johnson Services Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Services Product
Table 84. Johnson & Johnson Services Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Major Businesses
Table 87. Amgen Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Amgen Product
Table 89. Amgen Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Major Businesses
Table 92. Bristol-Myers Squibb Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. AbbVie Corporation Information
Table 96. AbbVie Description and Major Businesses
Table 97. AbbVie Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AbbVie Product
Table 99. AbbVie Recent Development
Table 100. Eli Lilly Corporation Information
Table 101. Eli Lilly Description and Major Businesses
Table 102. Eli Lilly Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Eli Lilly Product
Table 104. Eli Lilly Recent Development
Table 105. Global Antibodies Sales Forecast by Regions (2021-2026) (K Units)
Table 106. Global Antibodies Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Antibodies Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Antibodies Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 110. North America: Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 112. Europe: Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Antibodies Sales Forecast by Region (2021-2026) (K Units)
Table 114. Asia Pacific: Antibodies Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 116. Latin America: Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 118. Middle East and Africa: Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Antibodies Players
Table 123. Antibodies Customers List
Table 124. Antibodies Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibodies Product Picture
Figure 2. Global Antibodies Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal antibodies Product Picture
Figure 4. Polyclonal antibodies Product Picture
Figure 5. Antibody drug conjugates Product Picture
Figure 6. Global Antibodies Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Long-term care facilities
Figure 9. Research institutes
Figure 10. Antibodies Report Years Considered
Figure 11. Global Antibodies Market Size 2015-2026 (US$ Million)
Figure 12. Global Antibodies Sales 2015-2026 (K Units)
Figure 13. Global Antibodies Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Antibodies Sales Market Share by Region (2015-2020)
Figure 15. Global Antibodies Sales Market Share by Region in 2019
Figure 16. Global Antibodies Revenue Market Share by Region (2015-2020)
Figure 17. Global Antibodies Revenue Market Share by Region in 2019
Figure 18. Global Antibodies Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Antibodies Revenue in 2019
Figure 20. Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Antibodies Sales Market Share by Type (2015-2020)
Figure 22. Global Antibodies Sales Market Share by Type in 2019
Figure 23. Global Antibodies Revenue Market Share by Type (2015-2020)
Figure 24. Global Antibodies Revenue Market Share by Type in 2019
Figure 25. Global Antibodies Market Share by Price Range (2015-2020)
Figure 26. Global Antibodies Sales Market Share by Application (2015-2020)
Figure 27. Global Antibodies Sales Market Share by Application in 2019
Figure 28. Global Antibodies Revenue Market Share by Application (2015-2020)
Figure 29. Global Antibodies Revenue Market Share by Application in 2019
Figure 30. North America Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Antibodies Sales Market Share by Country in 2019
Figure 33. North America Antibodies Revenue Market Share by Country in 2019
Figure 34. U.S. Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Antibodies Market Share by Type in 2019
Figure 39. North America Antibodies Market Share by Application in 2019
Figure 40. Europe Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Antibodies Sales Market Share by Country in 2019
Figure 43. Europe Antibodies Revenue Market Share by Country in 2019
Figure 44. Germany Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Antibodies Market Share by Type in 2019
Figure 55. Europe Antibodies Market Share by Application in 2019
Figure 56. Asia Pacific Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Antibodies Sales Market Share by Region in 2019
Figure 59. Asia Pacific Antibodies Revenue Market Share by Region in 2019
Figure 60. China Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Antibodies Market Share by Type in 2019
Figure 83. Asia Pacific Antibodies Market Share by Application in 2019
Figure 84. Latin America Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Antibodies Sales Market Share by Country in 2019
Figure 87. Latin America Antibodies Revenue Market Share by Country in 2019
Figure 88. Mexico Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Antibodies Market Share by Type in 2019
Figure 95. Latin America Antibodies Market Share by Application in 2019
Figure 96. Middle East and Africa Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Antibodies Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Antibodies Revenue Market Share by Country in 2019
Figure 100. Turkey Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Antibodies Market Share by Type in 2019
Figure 107. Middle East and Africa Antibodies Market Share by Application in 2019
Figure 108. North America Antibodies Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Antibodies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Antibodies Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Antibodies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Antibodies Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Antibodies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Antibodies Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Antibodies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Antibodies Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Antibodies Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- 診断用特殊抗体の世界市場（～2026年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 20750 million by 2026, from US$ 20090 million in 2020, at a CAGR of 3.0%% during 2021-2026. Global Diagnostic Specialty Antibodies Scope and Ma…
- 癌治療用モノクローナル抗体の世界市場（～2026年） The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- HER2抗体の世界市場（～2026年） The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. Market Analysis and Insights: Global HER2 Antibodies Market The global HER2 Antibodies market size is projected to reach US$ 8543.4 million by 2026, from…
- 乳癌モノクローナル抗体の世界市場（～2026年） Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…